SourceOne brings Sytrinol to Europe

The distributor will work with supplier Solgar to bring Sytrinol for heart health to the European market following what the company says was a successful launch in the US.

"Working with Solgar on the launch of Sytrinol in the U.S. was a rewarding and successful experience and we look forward to building on this foundation of success with Solgar in the European market," said Jesse Lopez, president and CEO of SourceOne.

The finished product contains Sytrinol, a patented ingredient derived from citrus.

The Canadian-developed ingredient is composed of polymethoxylated flavones and tocotrienols.

According to SourceOne, clinical studies have shown Sytrinol to reduce total cholesterol by 30 percent, to reduce LDL cholesterol by 27 percent, as well as to lower triglycerides by 34 percent.

Leslie van der Meulen, director of sales with SourceOne, told NutraIngredients.com: " A natural science-based ingredient combination like Sytrinol that is patented is certain to have great impact on the overall heart health markets in the EU countries.

"There are few options available to the consumer that delivers multiple benefits that this formula of tocotrienols and PMFs delivers.

Sytrinol, besides its favorable effect on Cholesterol and triglycerides, has great anti-inflammatory capacity and is a powerful antioxidant as well."

Unlike other cholesterol supplements, it is claimed that Sytrinol is not diet specific and has no known side effects.

SourceOne has licensed the worldwide rights to patents and associated intellectual property for the use of Sytrinol in dietary supplements including capsules, bars, beverages and drink mixes.

"There are a number of application solutions possible for Sytrinol and other heart healthy ingredient combinations that are part of the SourceOne Cholesstrinol family of heart healthy formulas," said van der Meulen.

"Initially, the delivery system for Sytrinol is vegetarian capsules and soft gels.

We are currently working on other unique delivery systems and patented technologies to rapidly broaden the base of applications for our full line of heart healthy ingredient solutions.

Including CoQ10, omega-3, plant sterols and more."

The market for dietary supplements that lower cholesterol is said to be growing as those who suffer from related conditions prefer to take a natural alternative to pharmaceutical products.

As such there is room in the market for products such as Syntrinol, if consumers deem them to be effective.